West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 61,900 | 31,700 | 80,700 | 59,600 | 44,800 |
| Depreciation Amortization | 41,200 | 20,500 | 76,900 | 56,700 | 37,400 |
| Income taxes - deferred | N/A | N/A | 5,300 | N/A | N/A |
| Accounts receivable | N/A | N/A | -25,700 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 5,800 | N/A | N/A |
| Other Working Capital | -12,600 | -37,800 | -3,300 | -24,100 | -36,300 |
| Other Operating Activity | 7,900 | 4,500 | 47,700 | 25,400 | 20,100 |
| Operating Cash Flow | $98,400 | $18,900 | $187,400 | $117,600 | $66,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,900 | 4,200 | 14,400 | 4,800 | 1,300 |
| PPE Investments | -83,800 | -61,700 | -131,300 | -98,400 | -69,400 |
| Purchase Sale Intangibles | N/A | N/A | -700 | N/A | N/A |
| Other Investing Activity | -3,000 | -200 | 900 | 300 | 300 |
| Investing Cash Flow | $-81,900 | $-57,700 | $-116,000 | $-93,300 | $-67,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 43,300 | 43,300 | 168,100 | 168,000 | 0 |
| Debt Repayment | 149,000 | 90,100 | 352,400 | 258,900 | 32,900 |
| Common Stock Issued | 11,800 | 6,100 | 10,900 | 6,600 | 4,000 |
| Common Stock Repurchased | -5,200 | -2,900 | -4,700 | -2,200 | -2,200 |
| Dividend Paid | -13,100 | -6,500 | -24,900 | -18,300 | -12,200 |
| Other Financing Activity | -170,500 | -74,600 | -505,200 | -386,900 | -4,100 |
| Financing Cash Flow | $15,300 | $55,500 | $-3,400 | $26,100 | $18,400 |
| Exchange Rate Effect | -3,100 | -3,600 | 2,100 | 1,000 | -1,400 |
| Beginning Cash Position | 161,900 | 161,900 | 91,800 | 91,800 | 91,800 |
| End Cash Position | 190,600 | 175,000 | 161,900 | 143,200 | 107,000 |
| Net Cash Flow | $28,700 | $13,100 | $70,100 | $51,400 | $15,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 98,400 | 18,900 | 187,400 | 117,600 | 66,000 |
| Capital Expenditure | -83,800 | -61,700 | -131,300 | -98,400 | -69,400 |
| Free Cash Flow | 14,600 | -42,800 | 56,100 | 19,200 | -3,400 |